The large scale Phase 3 studies have begun as of April 2015 in Liberia and Sierra Leone, and in Guinea in March 2016.
W kwietniu 2015 r. w Liberii i Sierra Leone, i w Gwinei w marcu 2016 r. rozpoczęto szeroko zakrojone badania dotyczące fazy 3.